Pimavanserin and Aggression and Social Cognition. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pimavanserin and Aggression and Social Cognition. — Stella

Recruiting

Back to Intermittent Explosive Disorder trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

The Ohio State University College of Medicine, Columbus, Ohio

Key details

Phase

Safety & dosing

Sponsor

Ohio State University

Collaborators

ACADIA Pharmaceuticals Inc.

Enrollment target

~35 participants

Started

August 2024

Primary completion

January 2027

Age range

21 Years – 55 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov